HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120 ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012

Creator: Kovacs, JM

Contributor: Nkolola, JP
Peng, H.
Cheung, A.
Perry, J.
Miller, CA
Seaman, MS
Barouch, D.
Chen, B.
SpringerLink (Online service)

DOI: 10.1186/1742-4690-9-S2-O62

URN: urn:nbn:de:1111-2016080725529

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kovacs, JM
Nkolola, JP
Peng, H.
Cheung, A.
Perry, J.
Miller, CA
Seaman, MS
Barouch, D.
Chen, B.
SpringerLink (Online service)

Other Objects (12)

Eliciting neutralizing antibodies with gp120 outer domain

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

Eliciting neutralizing antibodies with gp120 outer domain

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

Eliciting neutralizing antibodies with gp120 outer domain

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Eliciting neutralizing antibodies with gp120 outer domain

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

Eliciting neutralizing antibodies with gp120 outer domain

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

Eliciting neutralizing antibodies with gp120 outer domain

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

Related objects

Reset password